Related references
Note: Only part of the references are listed.Sample Size Calculation for Gold-Standard Noninferiority Trials With Fixed Margins and Negative Binomial Endpoints
Gosuke Homma et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2021)
Optimal planning of adaptive two-stage designs
Maximilian Pilz et al.
STATISTICS IN MEDICINE (2021)
Most noninferiority trials were not designed to preserve active comparator treatment effects
Michael Tsui et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
A variational approach to optimal two-stage designs
Maximilian Pilz et al.
STATISTICS IN MEDICINE (2019)
Sequential parallel comparison design for gold standard noninferiority trials with a prespecified margin
Gosuke Homma et al.
BIOMETRICAL JOURNAL (2019)
Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective
Dave Singh et al.
RESPIRATORY RESEARCH (2019)
Guideline for the Diagnosis and Treatment of COPD Patients Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology
C. Vogelmeier et al.
PNEUMOLOGIE (2018)
Group-sequential three-arm noninferiority clinical trial designs
Toshimitsu Ochiai et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2017)
A studentized permutation test for three-arm trials in the 'gold standard' design
Tobias Muetze et al.
STATISTICS IN MEDICINE (2017)
Blinded sample size re-estimation in three-arm trials with gold standard' design
Tobias Muetze et al.
STATISTICS IN MEDICINE (2017)
Group sequential designs for three-arm 'gold standard' non-inferiority trials with fixed margin
Patrick Schloemer et al.
STATISTICS IN MEDICINE (2013)
A general approach for sample size calculation for the three-arm 'gold standard' non-inferiority design
Kathrin Stucke et al.
STATISTICS IN MEDICINE (2012)
Hierarchical testing of multiple endpoints in group-sequential trials
Ekkehard Glimm et al.
STATISTICS IN MEDICINE (2010)
Assessing non-inferiority of a new treatment in a three-arm trial in the presence of heteroscedasticity
Mario Hasler et al.
STATISTICS IN MEDICINE (2008)
Planning and analysis of three-arm non-inferiority trials with binary endpoints
Meinhard Kieser et al.
STATISTICS IN MEDICINE (2007)
Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials
H. M. James Hung et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2007)
Committee for medicinal products for human use (CHMP) guideline on the choice of the non-inferiority margin
[Anonymous]
STATISTICS IN MEDICINE (2006)
Efficient group sequential designs when there are several effect sizes under consideration
C Jennison et al.
STATISTICS IN MEDICINE (2006)
Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo
I Pigeot et al.
STATISTICS IN MEDICINE (2003)